Science in Action.
We are a 501(c)3 transforming how complex chronic inflammatory conditions are studied, diagnosed and treated.
Complex chronic inflammatory diseases are not mysterious or hopeless. The opposite is true: we can use new tools to study pathogen activity, environmental exposures, microbiome imbalances, neuroinflammation, gene changes, and other issues in patients with such conditions. PolyBio brings together some of the brightest minds in science to research these topics in a proactive and open-minded fashion.
CRISPR-Cas system discovery specialist at Mammoth Biosciences with a passion for developing & using technologies to identify novel genes from big data. Co-founder & Head of Bioinformatics at Ancilia Therapeutics focused on bacteriophage genomics and microbiome. Also an affiliate at the Lawrence Berkeley National Lab, Joint Genome Institute.
Scientist at the Max-Planck-Institute for Biology of Ageing working to understand how cellular organelles sense and respond to intracellular pathogens. Expert in mitochondrial dynamics, parasite biology, and immunometabolism.
Instructor in the Neurology Department of Massachusetts General Hospital & Harvard Medical School. Innovator of experimental models for the study of amyloid biology and infection in neurodegenerative disease.
Clinician-scientist determined to map inflammatory signatures specific to the microbiome in a creative fashion. Also an oral surgeon, Professor of Genomic Medicine, and member of the J. Craig Venter Institute infectious disease department. Life prior to disease is his mantra!
Physician at Spaulding Rehabilitation Hospital/Dean Center for Tickborne Illness and Pediatric Infectious Disease/Massachusetts General Hospital. Passionate about translating research on Borrelia burgdorferi and related tick-borne pathogens into cutting-edge clinical care.
Head of Business Development at Bloom Farms, a top-selling cannabis CPG company headquartered in California. Previously he spent eight years at the proprietary trading firm DRW, where he was in charge of the firm’s natural gas volatility portfolio. As an active angel investor, Dane seeks out companies in the Consumer Packaged Goods space in emerging categories focused on ancestral health. Dane holds a BA in Economics from Tufts University.
2x Olympic Gold Medalist and Captain of the USA Women’s Water Polo team. She is a dedicated leader not only to her team, but also to the sport of water polo and the growth of women in sport. This passion for growth is complimented by her entrepreneurial route with her company, 6-8 Sports, which she co-founded with fellow Olympian, Tony Azevedo. At 6-8 Sports, she focuses on business development & strategy and raising funds for the company to fulfill its mission. Maggie holds a Bachelor in Science in Science, Technology, and Society as well as a Master in Science in Management & Engineering from Stanford University.
Over 15 years of experience in the private equity and investment banking industries. He is currently a Partner at Newlight Partners, where he focuses on investments in power and infrastructure. Prior to joining Newlight he worked as Managing Director to its predecessor, the Strategic Investments Group of Soros Fund Management, as an Investment Banking Analyst for Bear Stearns, and as an Analyst for the Royal Bank of Scotland. Mark holds a Bachelor in Science and Foreign Service in International Economics from Georgetown University.
Innovating neuroscience and NOT psychology. We study the brain itself, with a focus on neuroinflammation, blood vessel issues, cerebrospinal fluid flow, and potential structural problems.
Research on root cause drivers of chronic inflammatory disease. Getting to the “root cause” of illness leads to development of the most effective treatments.
Exploring new frontiers. We prioritize research that moves beyond just blood tests and towards the study of tissue, nerves, cerebrospinal fluid & autopsies.